Adding a C-terminal Cysteine (CTC) Can Enhance the Bactericidal Activity of Three Different Antimicrobial Peptides

Efficient biosynthesis of a Cecropin A-melittin mutant in Bacillus subtilis WB700

(2017) Shengyue Ji et al.   Scientific Reports

In VivoandIn VitroEfficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii

(2016) Ya-Sung Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii

(2016) Mya Thandar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement

(2016) Heng-Li Chen et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability

(2016) Jasmeet Singh Khara et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Structure-Activity Relationship Study of Novel Peptoids That Mimic the Structure of Antimicrobial Peptides

(2015) Biljana Mojsoska et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Polymyxin B versus colistin: an update

(2015) Yiying Cai et al.   Expert Review of Anti-Infective Therapy

APD3: the antimicrobial peptide database as a tool for research and education

(2015) Guangshun Wang et al.   NUCLEIC ACIDS RESEARCH

High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia

(2015) Ali S Omrani et al.   Annals of Clinical Microbiology and Antimicrobials

Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-Line Antibiotics against Multidrug-Resistant Gram-Negative Bacteria

(2015) Kade D. Roberts et al.   ACS Infectious Diseases

Medium Effects on Minimum Inhibitory Concentrations of Nylon-3 Polymers against E. coli

(2014) Heejun Choi et al.   PLoS One

Host defense peptides: front-line immunomodulators

(2014) Sarah C. Mansour et al.   TRENDS IN IMMUNOLOGY

Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness

(2013) Rafael López-Rojas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections

(2013) Emil Lesho et al.   JOURNAL OF INFECTIOUS DISEASES

Identification of a Novel Antimicrobial Peptide from Human Hepatitis B Virus Core Protein Arginine-Rich Domain (ARD)

(2013) Heng-Li Chen et al.   PLoS Pathogens

Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design

(2012) Kamilia Abdelraouf et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: Nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program

(2012) Shu-Chen Kuo et al.   BMC INFECTIOUS DISEASES

Therapeutic Potential of Host Defense Peptides in Antibiotic-resistant Infections

(2012) Nicole J. Afacan et al.   CURRENT PHARMACEUTICAL DESIGN

Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a

(2012) Seema Joshi et al.   FEBS Journal

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II

(2012) Marc A. Fox et al.   PEPTIDES

Easy Strategy To Increase Salt Resistance of Antimicrobial Peptides

(2011) Hui-Yuan Yu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Designing antimicrobial peptides: form follows function

(2011) Christopher D. Fjell et al.   NATURE REVIEWS DRUG DISCOVERY

Nephrotoxicity Associated with Intravenous Colistin in Critically Ill Patients

(2011) Neha M Doshi et al.   PHARMACOTHERAPY

The expanding scope of antimicrobial peptide structures and their modes of action

(2011) Leonard T. Nguyen et al.   TRENDS IN BIOTECHNOLOGY

Adaptive Resistance to the "Last Hope" Antibiotics Polymyxin B and Colistin in Pseudomonas aeruginosa Is Mediated by the Novel Two-Component Regulatory System ParR-ParS

(2010) L. Fernandez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment ofAcinetobacterInfections

(2010) Joel Fishbain et al.   CLINICAL INFECTIOUS DISEASES

Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria

(2010) Junichi Taira et al.   JOURNAL OF PEPTIDE SCIENCE

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

(2008) Louis B. Rice   JOURNAL OF INFECTIOUS DISEASES